Thomas W. Dubensky

Chief Scientific Officer, CHINOOK THERAPEUTICS, INC.

Companies

Tempest Therapeutics, Inc.Board member Jun 29, 2021 to Jan 5, 2023¹
Tempest Therapeutics, Inc.President Jun 29, 2021 to Jan 5, 2023¹
HTG MOLECULAR DIAGNOSTICS, INCBoard member Aug 19, 2022 to Aug 22, 2022²
CHINOOK THERAPEUTICS, INC.Chief Scientific Officer Apr 14, 2015 to Aug 11, 2017³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Tempest Therapeutics, Inc. TPST113,343 shares⁴$68.5K at $0.60Jan 7, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 7, 2022Bought 2,000 shares at $4.78 of Tempest Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTempest Therapeutics, Inc., Board member
2
SEC EDGARHTG MOLECULAR DIAGNOSTICS, INC, Board member
3
SEC EDGARCHINOOK THERAPEUTICS, INC., Chief Scientific Officer
4
SEC EDGARTempest Therapeutics, Inc. shares after the filing of Jan 7, 2022